SJR 10
Urges Congress to take certain actions relating to the therapeutic use of certain psychedelic compounds. (BDR R-801)
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed Assembly
- To Governor
- Became Law
Bill overview
This bill urges the U.S. Congress to increase funding for research into the therapeutic uses of psychedelic compounds, such as psilocybin and MDMA, for treating mental health conditions, substance use disorders, and chronic pain. It also calls for streamlining the approval process for psychedelic research, establishing a process for compassionate medical use under the Right to Try Act, and potentially rescheduling these compounds to reflect their therapeutic value and low abuse potential. The bill recognizes growing federal and state interest in psychedelic therapies and seeks to support further research and legal protections.
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.